Major histocompatibility complex class II deficiency: a clinical review

Blood Reviews

Volumn 10, Issue 4, 1996, Pages 242-248

  Elhasid, R ^a   Etzioni, A ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANS ACTING FACTOR; TRANSACTIVATOR PROTEIN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; GENE CONTROL; GENE EXPRESSION; GENETIC COMPLEMENTATION; HISTOCOMPATIBILITY GENE; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; T LYMPHOCYTE;

EID: 0030465562     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90008-9     Document Type: Article

References (39)

1. Kimball SE, Caligan JE. Structure of class I major histocompatibility antigens. Top Mol Immmol 1983; 9: 1-6.
2. Korman AJ, Boss JM, Spies T, Sorrentino R, Okada K, Straninger JL. Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev 1985; 85: 45-50.
3. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7: 601-624.
4. Schmid SL, Jackson MR. Making class II presentable. Nature 1994; 369: 103-104.
5. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990; 8: 773-793.
6. Kappler JW, Rachm N, Marrack C. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273-280.
7. Tauraine JL, Betuel H, Souillet G. Combined immunodeficiency disease associated with absence of cell-surface HLA A and B antigens. J Pediatr 1978; 93: 47-51.
8. Payne R, Brodsky FM, Peterlin BM, Young LM. 'Bare lymphocytes' without immunodeficiency. Hum Immunol 1983; 6: 219-227.
9. Maeva H, Hirata R, Chen RF, Suzaki H, Kudoh S, Tohyama H. Defective expression of HLA class I antigens a case of the bare lymphocyte without immunodeficiency. Immunogenetics 1985; 21: 549-558.
10. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immun 1995: SI-S24.
11. Griscelli C, Grospierre BL, Mach B. Combined immunodeficiency with defective expression in MHC class II genes. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. London: Harwood Academic, 1993: 141-154.
12. Klein C, Grospierre BC, LeDeist F, Fischer A, Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 1993; 123: 921-928.
13. Wolf HM, Hauber I, Gulle H et al. Brief report: twin boys with major histocompatibility complex class II deficiency but inducible immune responses. N Engl J Med 1995; 332: 86-90.
14. Sonoyoma S, Etzioni A, Toru H, Pollack S, Aruffo A, Ochs HD. Immunological characterization of patients with MHC class II deficiency by analyzing CD40 and CD40 ligand system, submitted for publication.
15. Geha RS, Rosen FS, Chatila T. Primary immunodeficiency diseases. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia, PA: WB Saunders, 1993: 1033-1057.
16. Hong R, Clement LT, Gatti RA, Kirkpatrick CH. Disorders of the T-cell system. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. Philadelphia, PA: WB Saunders, 1996: 353-356.
17. Griscelli C, Grospierre BL. Combined immunodeficiency with defective expression in MHC class II genes. Immunodef Rev 1989; 1: 135-153.
18. Mach B, Steimle V, Reith W. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol Rev 1994; 138: 207-221.
19. de Preval, Hadam MR, Mach B. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency. N Engl J Med 1988; 318: 1295-1300.
20. Reith W, Satola S, Herrero SC et al. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein RF-X. Cell 1988; 53: 897-906.
21. Mach B. MHC class II regulation - lessons from a disease. N Engl J Med 1995; 332: 120-122.
22. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM. Activation of class IIMHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 1995; 2: 533-543.
23. Abdulkadir SA, Ono SJ. How are class IIMHC genes turned on and off? FASEB J 1995; 9: 1429-1435.
24. Benoist C, Mathis D. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990; 8: 681-715.
25. Kara CJ, Glimcher LH. In vivo footprinting of MHC class II genes: bare promoter in the bare lymphocyte syndrome. Science 1991; 252: 709-712.
26. Hume CR, Lee JS. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in transacting factors. Hum Immunol 1989; 26: 288-309.
27. Benichou B, Strominger JL. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 1991; 88: 4285-4288.
28. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135-146.
29. Rosen FS, Cooper MD, Wedgewood RJF. The primary immunodeficiencies. New Engl J Med 1995; 333: 431-440.
30. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 1995; 16: 539-546.
31. Chang CH, Guerder S, Hong SC, Ewijk WV, Flavell A. Mice lacking the MHC class II transactivator (CIITA) show tissue specific impairment of MHC class II expression. Immunity 1996; 4: 167-178.
32. Steimle V, Durand B, Barras E et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995; 9: 1021-1032.
33. Fondaneche MC, Felesczko W, Etzioni A, Fischer A, Lisowska-Grospierre B. A new complementation group in inherited MHC class II deficiency. VII. European Society for Immunodeficiency meeting, Goteberg, Sweden, June 96.
34. Grospierre BL, Fondaneche MC, Rois MP, Griscelli C, Fischer A. Two complementation groups account for most cases of inherited MHC class II deficiency. Hum Mol Genet 1994; 3: 953-958.
35. Fischer A, Friedrich W, Levinsky R et al. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985. Lancet 1986; 2: 1080-1084.
36. Casper JT, Ash RA, Kirchner P et al. Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ('bare lymphocyte syndrome'). J Pediatr 1990; 116: 262-265.
37. Fischer A, Landais P, Friedrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994; 83: 1149-1154.
38. Klein C, Cavazzana-Calvo M, Le Deist F et al. Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood 1995; 85: 580-587.
39. Fischer A, Friedrich W, Fasth A et al. Reduction of graft failure by a monoclonal antibody (anti -LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fonconi's anemia: a European Group for Immunodeficiency/ European Group for Bone Marrow Transplantation report. Blood 1991;77:249-256.